Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample

May 6, 2020

Presenters:

Casey Lester, MD

Carl Feinstein, MD

Target Audience

This activity was developed for physicians along with nurses and ancillary staff.

Learning Objectives

At the end of this presentation, participants should be better able to:

  • Discuss the latest evidence of the role of genetic predisposition to psychoses in the development of substance-induced psychotic disorder (SIPD)
  • Summarize the latest evidence regarding the roles of drug use and genetic predisposition in the progression from SIPD to schizophrenia
  • Identify known factors that signify higher risk of progression from SIPD to schizophrenia
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Course opens: 
05/06/2020
Course expires: 
10/31/2020
Event starts: 
05/06/2020 - 12:00pm
Event ends: 
05/06/2020 - 1:00pm
Cost:
$0.00
Rating: 
0
University of California School of Medicine at Riverside
Riverside, CA 92521
United States

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.